
CNXC Stock Forecast & Price Target
CNXC Analyst Ratings
Bulls say
Concentrix Corp is projected to experience improved revenue and non-GAAP EPS growth in fiscal years 2026 and 2027, driven by gains in market share and wallet share along with a strategic shift towards high-value solutions. The banking sector, a key area for the company, is anticipated to continue its robust growth trajectory, with increases expected in the high-single-digit to low-double-digit range across various financial institutions. Additionally, the company's technology solutions have shown significant traction, with technology wins rising by 61% year-over-year in fiscal Q1/26, indicating strong client acceptance and a shift in the go-to-market strategy.
Bears say
Concentrix Corp's financial performance has shown a concerning decline in key profitability metrics, with adjusted EBITDA margins falling year-over-year from 15.8% and sequentially from 14.8% to 13.9% in fiscal Q1/26. Additionally, the company's gross margins have decreased from 36.1% year-over-year and sequentially from 34.3% to 34.0%, indicating ongoing pressure on profitability. Moreover, challenges in core sectors, particularly healthcare, have contributed to an anticipated 6% year-over-year decline in adjusted EPS, compounded by unfavorable tax rate adjustments and continued headwinds from reduced Medicare enrollment.
This aggregate rating is based on analysts' research of Concentrix Corporation and is not a guaranteed prediction by Public.com or investment advice.
CNXC Analyst Forecast & Price Prediction
Start investing in CNXC
Order type
Buy in
Order amount
Est. shares
0 shares